Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Lung Cancer Highlights from ASCO 2005.

Belvedere O, Grossi F.

Oncologist. 2006 Jan;11(1):39-50.

3.

Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?

Buffoni L, VavalĂ  T, Novello S.

Curr Treat Options Oncol. 2016 Oct;17(10):54. doi: 10.1007/s11864-016-0429-x. Review.

PMID:
27523606
4.

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR.

J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22.

6.

Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.

Bunn PA Jr.

Clin Lung Cancer. 2004 Sep;6(2):85-98. Review.

PMID:
15476594
7.

A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.

Hainsworth JD, Gray JR, Litchy S, Bearden JD, Shaffer DW, Houston GA, Greco FA.

Clin Lung Cancer. 2004 Jul;6(1):33-42.

PMID:
15310415
8.
9.

Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.

Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ; Radiation Therapy Oncology Group.

J Clin Oncol. 2005 May 20;23(15):3480-7.

PMID:
15908657
10.
11.

Clinical studies in non-small cell lung cancer: the CALGB experience.

Vokes EE, Green MR.

Cancer Invest. 1998;16(2):72-9. Review.

PMID:
9512672
12.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, Smith TJ, Strawn JR, Trent D, Johnson DH; American Society of Clinical Oncology Clinical Practice.

J Clin Oncol. 2015 Oct 20;33(30):3488-515. doi: 10.1200/JCO.2015.62.1342. Epub 2015 Aug 31. Erratum in: J Clin Oncol. 2016 Apr 10;34(11):1287.

13.

Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.

Reynolds C, Barrera D, Jotte R, Spira AI, Weissman C, Boehm KA, Pritchard S, Asmar L.

J Thorac Oncol. 2009 Dec;4(12):1537-43. doi: 10.1097/JTO.0b013e3181c0a2f4.

14.

First-line treatment for advanced non-small-cell lung cancer.

Laskin JJ, Sandler AB.

Oncology (Williston Park). 2005 Nov;19(13):1671-6; discussion 1678-80. Review.

15.

[Combined-modality therapy for lung cancer].

Miura S, Yamamoto N.

Nihon Rinsho. 2010 Jun;68(6):1121-8. Review. Japanese.

PMID:
20535966
16.
17.

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, Scagliotti G, Rosell R, Oliff I, Reeves JA, Wolf MK, Krebs AD, Averbuch SD, Ochs JS, Grous J, Fandi A, Johnson DH.

J Clin Oncol. 2004 Mar 1;22(5):785-94.

PMID:
14990633
18.
19.

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):327-39. Review.

PMID:
11441939
20.

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.

Cancer Prev Control. 1997 Aug;1(3):249-59.

PMID:
9765750

Supplemental Content

Support Center